News
Yet, even as we celebrate these strengths, it is clear that the next phase of growth will not be driven by volume alone. To remain globally competitive and meet the complex health needs of the future, ...
4d
Trade Brains on MSNPharma stock falls 4% after competitor acquires U.S. patent for heart failure medicineThe shares of one of India's leading API manufacturers, engaged in the production and export of APIs, intermediates, and ...
The government has moved to complete the process of plot transfers at the Active Pharmaceutical Ingredient (API) Industrial ...
Global active pharmaceutical ingredients (API) market will reach $ 386.2 billion by 2032, growing by 6.4% annually over 2022-2032, driven by rising adoption of biologics in disease management, ...
North America active pharmaceutical ingredients (API) market is projected to grow by 4.8% annually in the forecast period and reach $120.7 billion by 2032, driven by rising adoption of biologics in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results